IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages

Li-Zong Rao,Yi Wang,Lei Zhang,Guorao Wu,Lu Zhang,Fa-Xi Wang,Long-Min Chen,Fei Sun,Song Jia,Shu Zhang,Qilin Yu,Jiang-Hong Wei,Hui-Ren Lei,Ting Yuan,Jinxiu Li,Xingxu Huang,Bin Cheng,Jianping Zhao,Yongjian Xu,Bi-Wen Mo,Cong-Yi Wang,Huilan Zhang

DOI: https://doi.org/10.1038/s41418-020-00650-6

IF: 12.067

2020-11-03

Cell Death and Differentiation

Abstract:Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial pneumonia and has one of the poorest prognosis. However, the molecular mechanisms underlying IPF progression remain largely unknown. In this study, we determined that IL-24, an IL-20 subfamily cytokine member, was increased both in the serum of IPF patients and the bronchoalveolar lavage fluid (BALF) of mice following bleomycin (BLM)-induced pulmonary fibrosis. As a result, <i>IL-24</i> deficiency protected mice from BLM-induced lung injury and fibrosis. Specifically, loss of <i>IL-24</i> significantly attenuated transforming growth factor β1 (TGF-β1) production and reduced M2 macrophage infiltration in the lung of BLM-induced mice. Mechanistically, IL-24 alone did not show a perceptible impact on the induction of M2 macrophages, but it synergized with IL-4 to promote M2 program in macrophages. IL-24 suppressed IL-4-induced expression of suppressor of cytokine signaling 1 (SOCS1) and SOCS3, through which it enhanced signal transducer and activator of transcription 6/peroxisome proliferator-activated receptor gamma (STAT6/PPARγ) signaling, thereby promoting IL-4-induced production of M2 macrophages. Collectively, our data support that IL-24 synergizes with IL-4 to promote macrophage M2 program contributing to the development of pulmonary fibrosis.

cell biology,biochemistry & molecular biology

What problem does this paper attempt to address?

This paper aims to explore the mechanism of action of IL - 24 in idiopathic pulmonary fibrosis (IPF). Specifically, it studied how IL - 24 deficiency protects mice from bleomycin (BLM) - induced pulmonary fibrosis by inhibiting the IL - 4 - induced M2 macrophage program. The study found that the expression of IL - 24 was increased in the serum of IPF patients and in the bronchoalveolar lavage fluid (BALF) of BLM - induced pulmonary fibrosis mice. IL - 24 deficiency significantly alleviated BLM - induced lung injury and fibrosis in mice, as manifested by reduced production of transforming growth factor β1 (TGF - β1) and reduced infiltration of M2 macrophages. Further mechanistic studies showed that IL - 24 itself had no obvious effect on the differentiation of M2 macrophages, but synergized with IL - 4 to enhance signal transducer and activator of transcription 6 (STAT6)/peroxisome proliferator - activated receptor γ (PPAR - γ) signaling by inhibiting the expression of IL - 4 - induced suppressor of cytokine signaling 1 (SOCS1) and SOCS3, thereby promoting IL - 4 - induced M2 macrophage production. In conclusion, the research results indicate that IL - 24 synergizes with IL - 4 and participates in the occurrence and development of pulmonary fibrosis by promoting the macrophage M2 program.